Biohit Oyj

Report Publication Announcement • Apr 27, 2017

Disclosure 351631

Biohit Oyj - Other information disclosed according to the rules of the Exchange

Constitutive meeting of Biohit Oyj’s Board of Directors

Biohit Oyj Other information disclosed according to the rules of the Exchange April 27, 2017 at 9:30 am local time (EEST)

Biohit Oyj’s Board of Directors has in its meeting yesterday elected Mr Osmo Suovaniemi as the Chairman of the Board of Directors.

Additional information:

CEO Semi Korpela, Biohit Oyj

tel. +358 9 773 861

investor.relations@biohit.fi

www.biohithealthcare.com

Biohit in brief

Biohit Oyj is a globally operating Finnish biotechnology company. Biohit’s mission is “Innovating for Health” – we produce innovative products and services to promote research and early diagnosis. Biohit is headquartered in Helsinki, Finland, and has subsidiaries in Italy and the UK. Biohit's Series B share (BIOBV) is quoted on Nasdaq Helsinki in the Small cap/Healthcare group. www.biohithealthcare.com